CA2020199A1 - Utilisation de sucres sulfates - Google Patents
Utilisation de sucres sulfatesInfo
- Publication number
- CA2020199A1 CA2020199A1 CA 2020199 CA2020199A CA2020199A1 CA 2020199 A1 CA2020199 A1 CA 2020199A1 CA 2020199 CA2020199 CA 2020199 CA 2020199 A CA2020199 A CA 2020199A CA 2020199 A1 CA2020199 A1 CA 2020199A1
- Authority
- CA
- Canada
- Prior art keywords
- skin
- treatment
- prophylaxis
- medicament
- connective tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000000346 sugar Nutrition 0.000 title 1
- 150000008163 sugars Chemical class 0.000 title 1
- 238000011282 treatment Methods 0.000 abstract 5
- 238000011321 prophylaxis Methods 0.000 abstract 4
- 210000002808 connective tissue Anatomy 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- 210000002200 mouth mucosa Anatomy 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 2
- 230000002496 gastric effect Effects 0.000 abstract 2
- 230000003211 malignant effect Effects 0.000 abstract 2
- 239000002674 ointment Substances 0.000 abstract 2
- 230000000699 topical effect Effects 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000034693 Laceration Diseases 0.000 abstract 1
- 208000002847 Surgical Wound Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 150000002016 disaccharides Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 230000008105 immune reaction Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 239000006210 lotion Substances 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 150000002772 monosaccharides Chemical class 0.000 abstract 1
- 239000006072 paste Substances 0.000 abstract 1
- 239000011505 plaster Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 230000008439 repair process Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 230000036269 ulceration Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2020199 CA2020199C (fr) | 1990-06-29 | 1990-06-29 | Utilisation de sucres sulfates |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2020199 CA2020199C (fr) | 1990-06-29 | 1990-06-29 | Utilisation de sucres sulfates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2020199A1 true CA2020199A1 (fr) | 1991-12-30 |
| CA2020199C CA2020199C (fr) | 2002-08-20 |
Family
ID=4145381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2020199 Expired - Fee Related CA2020199C (fr) | 1990-06-29 | 1990-06-29 | Utilisation de sucres sulfates |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2020199C (fr) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6083933A (en) * | 1999-04-19 | 2000-07-04 | Stellar International Inc. | Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution |
| US7772210B2 (en) | 2003-02-19 | 2010-08-10 | Stellar Pharmaceuticals Inc. | Cystitis treatment with high dose chondroitin sulfate |
| WO2020076501A1 (fr) * | 2018-10-10 | 2020-04-16 | Hollister Incorporated | Poudre pour stomie comprenant des ingrédients de santé de la peau |
| US11291684B2 (en) | 2017-05-17 | 2022-04-05 | Tx Medic Ab | Treatment of glaucoma |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2908911A1 (fr) * | 2012-10-17 | 2015-08-26 | Interalia S.r.l. | Compositions comprenant un sel d'argent d'octasulfate de saccharose et un sel de potassium d'octasulfate de saccharose pour la protection des épithéliums de muqueuse |
-
1990
- 1990-06-29 CA CA 2020199 patent/CA2020199C/fr not_active Expired - Fee Related
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6083933A (en) * | 1999-04-19 | 2000-07-04 | Stellar International Inc. | Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution |
| US7772210B2 (en) | 2003-02-19 | 2010-08-10 | Stellar Pharmaceuticals Inc. | Cystitis treatment with high dose chondroitin sulfate |
| US8084441B2 (en) | 2003-02-19 | 2011-12-27 | Stellar Pharmaceuticals, Inc. | Cystitis treatment with high dose chondroitin sulfate |
| US8334276B2 (en) | 2003-02-19 | 2012-12-18 | Stellar Pharmaceuticals Inc. | Cystitis treatment with high dose chondroitin sulfate |
| US8778908B2 (en) | 2003-02-19 | 2014-07-15 | Stellar International Inc. | Cystitis treatment with high dose chondroitin sulfate |
| US11291684B2 (en) | 2017-05-17 | 2022-04-05 | Tx Medic Ab | Treatment of glaucoma |
| WO2020076501A1 (fr) * | 2018-10-10 | 2020-04-16 | Hollister Incorporated | Poudre pour stomie comprenant des ingrédients de santé de la peau |
| CN113038935A (zh) * | 2018-10-10 | 2021-06-25 | 霍利斯特公司 | 含有皮肤愈合成分的造口粉 |
| AU2019356464B2 (en) * | 2018-10-10 | 2024-08-22 | Hollister Incorporated | Stoma powder including skin health ingredients |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2020199C (fr) | 2002-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK151590A (da) | Anvendelse af sulfaterede sukkerarter | |
| ATE363283T1 (de) | Terfenadin-carboxylat und die behandlung von hautreizung | |
| CA2000548A1 (fr) | Bandage confortable et enduit | |
| US5420114A (en) | Methods for the treatment of skin disorders | |
| PL330768A1 (en) | Perpetration for use in therapy and prophylactics of dermatological diseases | |
| EP0219455A3 (fr) | Compositions pharmaceutiques ou cosmétiques contenant de la N-acétylcystéine | |
| WO2004100923A1 (fr) | Composition a usage externe administree par voie percutanee | |
| CA2020199A1 (fr) | Utilisation de sucres sulfates | |
| JPH0522689B2 (fr) | ||
| IT1230157B (it) | Uso di sucralfato gel umido per il trattamento di ulcere del derma e come veicolo di farmaci ad attivita' topica | |
| CN105169457B (zh) | 一种阳离子医用敷料及其制备方法 | |
| EP0242553A1 (fr) | Utilisation d'allantoine et de soufre dans la préparation d'un médicament pour le traitement de maladies odontostomatologiques | |
| JP2004534076A (ja) | 傷の治療および再上皮形成のための糖蛋白質の使用 | |
| JPH039885B2 (fr) | ||
| CN105056288B (zh) | 医用痔疮生物水凝胶功能敷料及其制备方法 | |
| FR2757391B1 (fr) | Utilisation d'un extrait de la plante terminalia, dans les domaines cosmetique et pharmaceutique, notamment dermatologique | |
| CN105616296A (zh) | 一种杨枸花止痒护肤泥 | |
| US20050191354A1 (en) | Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent | |
| CA2126704C (fr) | Compositions dermatologiques et methodes de traitement de la peau | |
| KR20040087006A (ko) | 수용성 고분자를 이용한 시이트형 하이드로겔 팩제 및 그제조방법 | |
| SU1475669A1 (ru) | Средство дл профилактики и лечени отморожений | |
| HODGSON et al. | A clinical comparison between triacetoxyanthracene and dithranol pastes in the treatment of chronic psoriasis | |
| US7018661B2 (en) | Aluminum-zirconium compound-based treatment for herpes simplex virus lesions | |
| CA2097878A1 (fr) | Agent therapeutique pour la neutropenie | |
| WO2000024370A1 (fr) | Gels dermatologiques pour le traitement de l'acne simple et de l'herpes contenant de la methenamine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |